Asia Pacific Endothelial Dysfunction Market

Historic Data: 2020-2021   |   Base Year: 2022   |    Forecast Period: 2023-2028

Analysis - by Cause (Hypertension, Diabetes, Hypercholestrolaemia, Bechet\'s Disease, Obesity, and Others), Test Type [Invasive Tests and Non-Invasive Tests (Flow Mediated Dilatory, Peripheral Arterial Tonometry (PAT), Venous Occlusion Pletismography, Circulating Markers, and Others)], and End User (Hospitals, Ambulatory Surgery Centers, Specialty Clinics, and Others)

No. of Pages: 128  |  Report Code: BMIRE00029598  |  Category: Life Sciences

Available Report Formats

pdf-format excel-format pptx-format
Buy Now
Asia Pacific Endothelial Dysfunction Market
Free Sample Buy Now

The Asia Pacific endothelial dysfunction market is expected to grow from US$ 304.48 million in 2022 to US$ 405.51 million by 2028. It is estimated to grow at a CAGR of 4.9% from 2022 to 2028.



Rising Usage of Novel Biomarkers and Therapeutic Strategies Fuels Asia Pacific Endothelial Dysfunction Market



Examining endothelial function can improve risk stratification, improve early disease detection, and assess vascular response to therapeutic interventions. There are studies to understand the pathophysiological mechanisms underlying endothelial dysfunction and atherosclerosis progression in a better way and identify new biomarkers and therapeutic strategies to prevent endothelial dysfunction and atherosclerosis to reduce the risk of developing coronary artery disease (CAD) and related complications. Using liquid biopsies and new molecular biology techniques has enabled the identification of a growing list of molecular and cellular markers of endothelial dysfunction that have provided insight into the molecular basis of atherosclerosis as well as potential biomarkers and therapeutic targets for the prevention and treatment of atherosclerosis and CAD.

Research on biomarkers and their clinical application has increased exponentially over the last few decades. Invaluable insight into the pathophysiology of atherosclerosis and the development of novel therapies have been provided by systemic biomarkers. Endothelial dysfunction and inflammation play a central role in the development and progression of CAD. Inflammatory mediators are secreted by inflammatory and vascular cells in atherosclerotic plaque or by organs such as the liver or adipose tissue.

Asia Pacific Endothelial Dysfunction Market Overview



The endothelial dysfunction market in Asia Pacific is segmented into China, Japan, India, South Korea, Australia, and the Rest of Asia Pacific. The growth of the market in the region is attributed to the increasing cases of endothelial dysfunction with the rising incidence of CVD, hypertension, diabetes, and chronic diseases, coupled with the growing aging population. In addition, the market is driven by increasing investments in diagnostics techniques by the respective country governments, resulting in advancements in diagnostics methods.

Asia Pacific Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)

Market Revenue and Forecast Overview
Get more information on this report

Asia Pacific Endothelial Dysfunction Strategic Insights

Strategic insights for the Asia Pacific Endothelial Dysfunction provides data-driven analysis of the industry landscape, including current trends, key players, and regional nuances. These insights offer actionable recommendations, enabling readers to differentiate themselves from competitors by identifying untapped segments or developing unique value propositions. Leveraging data analytics, these insights help industry players anticipate the market shifts, whether investors, manufacturers, or other stakeholders. A future-oriented perspective is essential, helping stakeholders anticipate market shifts and position themselves for long-term success in this dynamic region. Ultimately, effective strategic insights empower readers to make informed decisions that drive profitability and achieve their business objectives within the market.

Market Revenue and Forecast Overview
Get more information on this report

Asia Pacific Endothelial Dysfunction Report Scope

Report Attribute Details
Market size in 2022 US$ 304.48 Million
Market Size by 2028 US$ 405.51 Million
Global CAGR (2022 - 2028) 4.9%
Historical Data 2020-2021
Forecast period 2023-2028
Segments Covered By Cause
  • Hypertension
  • Diabetes
  • Hypercholestrolaemia
  • Bechet's Disease
  • Obesity
By Test Type
  • Invasive Tests and Non-Invasive Tests
By End User
  • Hospitals
  • Ambulatory Surgery Centers
  • Specialty Clinics
Regions and Countries Covered Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
Market leaders and key company profiles
  • Medizinische Messtechnik GmbH
  • Perimed AB
  • Sphingo Tec GmbH
  • ZOLL Medical Corp
Get more information on this report

Asia Pacific Endothelial Dysfunction Regional Insights

The geographic scope of the Asia Pacific Endothelial Dysfunction refers to the specific areas in which a business operates and competes. Understanding local distinctions, such as diverse consumer preferences (e.g., demand for specific plug types or battery backup durations), varying economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved areas or adapting their offerings to meet local demands. A clear market focus allows for more effective resource allocation, targeted marketing campaigns, and better positioning against local competitors, ultimately driving growth in those targeted areas.

Market Revenue and Forecast Overview
Get more information on this report

Asia Pacific Endothelial Dysfunction Market Segmentation 


The Asia Pacific endothelial dysfunction market is segmented into cause, test type, end user, and country. 

Based on cause, the Asia Pacific endothelial dysfunction market is segmented into hypertension, hypercholesterolaemia, obesity, diabetes, Behcet's disease, and others. The hypertension segment registered the largest Asia Pacific endothelial dysfunction market share in 2022.

Based on test type, the Asia Pacific endothelial dysfunction market is segmented into invasive test and non-invasive test. The invasive test segment held a larger Asia Pacific endothelial dysfunction market share in 2022. The non-invasive test segment is further subsegmented into flow mediated dilatory, peripheral arterial tonometry (PAT), venous occlusion pletismography, circulating markers, and others.

Based on end user, the Asia Pacific endothelial dysfunction market has been categorized into hospitals, diagnostic centers, clinics, and others. The hospitals segment held the largest Asia Pacific endothelial dysfunction market share in 2022. 

Based on country, the Asia Pacific endothelial dysfunction market is segmented into China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. China dominated the Asia Pacific endothelial dysfunction market in 2022. 

ZOLL Medical Corp, Sphingo Tec GmbH, Perimed AB, and Medizinische Messtechnik GmbH are some of the leading companies operating in the endothelial dysfunction market in the region.

Identical Market Reports with other Region/Countries

The List of Companies - Asia Pacific Endothelial Dysfunction Market



1. Medizinische Messtechnik GmbH

2. Perimed AB

3. Sphingo Tec GmbH

4. ZOLL Medical Corp

Frequently Asked Questions
How big is the Asia Pacific Endothelial Dysfunction Market?

The Asia Pacific Endothelial Dysfunction Market is valued at US$ 304.48 Million in 2022, it is projected to reach US$ 405.51 Million by 2028.

What is the CAGR for Asia Pacific Endothelial Dysfunction Market by (2022 - 2028)?

As per our report Asia Pacific Endothelial Dysfunction Market, the market size is valued at US$ 304.48 Million in 2022, projecting it to reach US$ 405.51 Million by 2028. This translates to a CAGR of approximately 4.9% during the forecast period.

What segments are covered in this report?

The Asia Pacific Endothelial Dysfunction Market report typically cover these key segments-

  • Cause (Hypertension, Diabetes, Hypercholestrolaemia, Bechet\'s Disease, Obesity)
  • Test Type (Invasive Tests and Non-Invasive Tests)
  • End User (Hospitals, Ambulatory Surgery Centers, Specialty Clinics)

    • What is the historic period, base year, and forecast period taken for Asia Pacific Endothelial Dysfunction Market?

    The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Asia Pacific Endothelial Dysfunction Market report:

  • Historic Period : 2020-2021
  • Base Year : 2022
  • Forecast Period : 2023-2028
    • Who are the major players in Asia Pacific Endothelial Dysfunction Market?

    The Asia Pacific Endothelial Dysfunction Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:

  • Medizinische Messtechnik GmbH
  • Perimed AB
  • Sphingo Tec GmbH
  • ZOLL Medical Corp
    • Who should buy this report?

    The Asia Pacific Endothelial Dysfunction Market report is valuable for diverse stakeholders, including:

    • Investors: Provides insights for investment decisions pertaining to market growth, companies, or industry insights. Helps assess market attractiveness and potential returns.
    • Industry Players: Offers competitive intelligence, market sizing, and trend analysis to inform strategic planning, product development, and sales strategies.
    • Suppliers and Manufacturers: Helps understand market demand for components, materials, and services related to concerned industry.
    • Researchers and Consultants: Provides data and analysis for academic research, consulting projects, and market studies.
    • Financial Institutions: Helps assess risks and opportunities associated with financing or investing in the concerned market.

    Essentially, anyone involved in or considering involvement in the Asia Pacific Endothelial Dysfunction Market value chain can benefit from the information contained in a comprehensive market report.

    asia-pacific-endothelial-dysfunction-market